In Brief: Vitamin E
This article was originally published in The Tan Sheet
Executive Summary
Vitamin E: "May slow or prevent kidney disease," according to a study by Gerald Appel, MD, Columbia University et al., and Roche. Released Nov. 3 at the American Society of Nephrology annual meeting in New Orleans, the study found that vitamin E doses of 30-300 mg/day in nine diabetic microalbuminuria sufferers reduced levels of soluble vascular cell adhesion molecule-1 by a mean of 14% after eight weeks of administration. VCAM-1 is a possible surrogate marker for effectiveness of interventions aimed at treating diabetic nephropathy...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: